Prior to retirement Barbara was Associate Vice President at Sanofi-Aventis, U. S. responsible for development and maintenance of Corporate, United States and European Union labeling for prescription products and biologics across several therapeutic areas. Previously to that position Barbara was a Senior Director at Merck and Co., heading the Global Labeling department within Regulatory Affairs. Currently, she continues as an Associate Adjunct Professor at Temple University School of Pharmacy in the Regulatory Affairs/Quality Assurance Master's program.